Iron Metabolism Regulates p53 Signaling through Direct Heme-p53 Interaction and Modulation of p53 Localization, Stability, and Function

Iron excess is closely associated with tumorigenesis in multiple types of human cancers, with underlying mechanisms yet unclear. Recently, iron deprivation has emerged as a major strategy for chemotherapy, but it exerts tumor suppression only on select human malignancies. Here, we report that the tumor suppressor protein p53 is downregulated during iron excess. Strikingly, the iron polyporphyrin heme binds to p53 protein, interferes with p53-DNA interactions, and triggers both nuclear export and cytosolic degradation of p53. Moreover, in a tumorigenicity assay, iron deprivation suppressed wild-type p53-dependent tumor growth, suggesting that upregulation of wild-type p53 signaling underlies the selective efficacy of iron deprivation. Our findings thus identify a direct link between iron/heme homeostasis and the regulation of p53 signaling, which not only provides mechanistic insights into iron-excess-associated tumorigenesis but may also help predict and improve outcomes in iron-deprivation-based chemotherapy

DMAP-catalyzed cyclization of Schiff bases with α-halo ketones: Synthesis of 1,4-benzoxazines

<p>We demonstrate that 1,4-benzoxazines can be efficiently synthesized using 4-dimethylaminopyridine (DMAP) as a catalyst. We found that the DMAP catalyst can successfully promote the incorporation of the activated carbon atoms of α-halo ketones into the Schiff bases. The 1,4-benzoxazines can be synthesized through the formation of C–O and C–C bonds in high yield, using DMAP as the catalyst, α-halo ketones and phenolic Schiff bases as the reactants. Furthermore, a possible mechanism is proposed. This work provides a simple and efficient route to prepare the 1,4-benzoxazines.</p